Literature DB >> 8563455

The autonomic nervous system and the regulation of arterial tone in migraine.

L L Thomsen1, J Olesen.   

Abstract

Abnormal regulation of the large cranial arteries seems to play a significant role in the mechanisms of migraine pain. Thus, vasodilatation of extra- and intracranial conductance arteries has been described both during spontaneous migraine attacks and during experimentally provoked vascular headaches. The regulation of the diameter of these arteries is complex and involves autonomic, trigeminovascular, endothelial and humoral mechanisms. Studies concerned with the function of the autonomic nervous system in migraine suggest that a mild parasympathetic dysfunction may be present. Cerebral arteries in migraineurs are hypersensitive to nitric oxide, which may induce migraine attacks. As the enzyme responsible for nitric oxide synthesis is present in parasympathetic nerve endings around cerebral arteries, this supports a role for the parasympathetic nervous system in migraine. In addition, vasoactive transmitters released from perivascular trigeminal nerve endings may be implicated. Several of these aspects are closely linked to the presumed mechanisms of action of modern migraine therapeutics.

Entities:  

Mesh:

Year:  1995        PMID: 8563455     DOI: 10.1007/bf01818887

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  84 in total

1.  Catecholamines and migraine: evidence based on biofeedback induced changes.

Authors:  R J Mathew; B T Ho; P Kralik; D Taylor; J L Claghorn
Journal:  Headache       Date:  1980-09       Impact factor: 5.887

2.  Reflex vasomotor function: clinical and experimental studies in migraine.

Authors:  O Appenzeller
Journal:  Res Clin Stud Headache       Date:  1978

3.  Platelet as a model to test autonomic function in migraine.

Authors:  G D'Andrea; A R Cananzi; M Morra; S Fornasiero; F Zamberlan; F Ferro-Milone; R Joseph; S Grunfeld; K M Welch
Journal:  Funct Neurol       Date:  1989 Jan-Mar

4.  Reflex vasomotor responses in the hands of migrainous subjects.

Authors:  E B French; B W Lassers; M G Desai
Journal:  J Neurol Neurosurg Psychiatry       Date:  1967-06       Impact factor: 10.154

5.  Vasoactive peptide release in the extracerebral circulation of humans during migraine headache.

Authors:  P J Goadsby; L Edvinsson; R Ekman
Journal:  Ann Neurol       Date:  1990-08       Impact factor: 10.422

6.  The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater.

Authors:  M G Buzzi; M A Moskowitz
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

7.  Vascular reactivity during migraine attacks: a transcranial Doppler study.

Authors:  C P Zwetsloot; J F Caekebeke; J Odink; M D Ferrari
Journal:  Headache       Date:  1991-10       Impact factor: 5.887

Review 8.  Neurogenic inflammation in the pathophysiology and treatment of migraine.

Authors:  M A Moskowitz
Journal:  Neurology       Date:  1993-06       Impact factor: 9.910

9.  Absence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura.

Authors:  L Friberg; J Olesen; T S Olsen; A Karle; R Ekman; J Fahrenkrug
Journal:  Cephalalgia       Date:  1994-02       Impact factor: 6.292

10.  Early morning migraine. Nocturnal plasma levels of catecholamines, tryptophan, glucose, and free fatty acids and sleep encephalographs.

Authors:  L K Hsu; A H Crisp; R S Kalucy; J Koval; C N Chen; M Carruthers; K J Zilkha
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321

View more
  6 in total

1.  The effect of rizatriptan, ergotamine, and their combination on human peripheral arteries: a double-blind, placebo-controlled, crossover study in normal subjects.

Authors:  Peer Tfelt-Hansen; Kaj Seidelin; Michael Stepanavage; Christopher Lines
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

2.  [Importance of perimetric differential diagnostics in patients with primary open-angle glaucoma].

Authors:  C Erb; K Göbel
Journal:  Ophthalmologe       Date:  2013-02       Impact factor: 1.059

3.  Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial.

Authors:  Piero Barbanti; Luisa Fofi; Valentina Dall'Armi; Cinzia Aurilia; Gabriella Egeo; Nicola Vanacore; Stefano Bonassi
Journal:  J Headache Pain       Date:  2012-03-30       Impact factor: 7.277

4.  Parasympathetic Nervous System Dysfunction, as Identified by Pupil Light Reflex, and Its Possible Connection to Hearing Impairment.

Authors:  Yang Wang; Adriana A Zekveld; Graham Naylor; Barbara Ohlenforst; Elise P Jansma; Artur Lorens; Thomas Lunner; Sophia E Kramer
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

5.  Low-frequency facial hemodynamic oscillations distinguish migraineurs from non-headache controls.

Authors:  Melissa M Cortez; Jeremy J Theriot; Natalie A Rea; Forrest E Gowen; K C Brennan
Journal:  Cephalalgia Rep       Date:  2019-11-14

6.  Cardiovascular responses to cognitive stress in patients with migraine and tension-type headache.

Authors:  Rune B Leistad; Trond Sand; Kristian B Nilsen; Rolf H Westgaard; Lars Jacob Stovner
Journal:  BMC Neurol       Date:  2007-08-07       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.